CONSULTING AGREEMENTConsulting Agreement • August 14th, 2013 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 14th, 2013 Company Industry JurisdictionThis Consulting Agreement (this “Agreement”) is made and entered into as of December 31, 2012 by and between Fate Therapeutics, Inc., a Delaware corporation (the “Company”), and John D. Mendlein (“Consultant”).
CONSULTING AGREEMENTConsulting Agreement • June 20th, 2013 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledJune 20th, 2013 Company Industry JurisdictionThis Consulting Agreement (this “Agreement”) is made and entered into as of December 31, 2012 by and between Fate Therapeutics, Inc., a Delaware corporation (the “Company”), and John D. Mendlein (“Consultant”).